Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
- 31 December 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 136 (6), 1049-1061
- https://doi.org/10.1016/s0002-9394(03)00576-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Patients With Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- EFFECTS OF VERTEPORFIN THERAPY ON CONTRAST SENSITIVITYRetina, 2002
- Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSESRetina, 2002
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfinOphthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- The second eye of Japanese patients with unilateral exudative age related macular degenerationBritish Journal of Ophthalmology, 2000
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- SYMPTOMATIC AGE-RELATED MACULAR DEGENERATION IN ASIAN PATIENTSRetina, 1998
- Choroidal Neovascularization in Black PatientsArchives of Ophthalmology (1950), 1994